The most well-known utilization of Dexlansoprazole is
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
The use of Delanix 30mg Capsule may cause excessive drowsiness and calmness with alcohol.
Delanix 30mg Capsule should be avoided by pregnant women unless suggested by the doctor. The effect of this medicine on the fetus is not clearly established and hence, doctor consultation is recommended before consumption.
Delanix 30mg Capsule may pass into breast milk and cause side effects in breastfed babies. An alternate medicine may be preferred, especially while nursing a newborn or preterm infant. If required, it should only be used upon your doctor's recommendation.
There is no interaction between driving and consuming this drug. So dose alteration is not needed.
There is no interaction between renal impairment and consuming Delanix 30mg Capsule. So dose alteration is not needed.
No dose adjustment is needed for patients with mild to moderate liver disease. Not advisable in patients with severe liver disease.
Delanix 30mg Capsule belongs to the class of medications known as proton pump inhibitors (PPIs). The stomach's acid secretion is regulated by a specific type of enzyme called the proton pump. Delanix 30mg Capsule works by blocking the final step of acid production in the gastric parietal cells, which are responsible for secreting gastric acid. This suppression of acid production helps in reducing the acidity in the stomach.
Delanix 30mg Capsule is an anti-ulcer medication used to treat conditions characterized by excessive stomach acid production. It is effective in treating heartburn associated with non-erosive gastroesophageal reflux disease (GERD), where stomach acid and bile irritate the food pipe. Additionally, Delanix 30mg Capsule Capsule aids in healing the damage caused to the esophagus (food pipe) due to excess acid production. By interfering with the final step of acid release in the stomach, it reduces acidity and promotes faster ulcer healing.
A proton pump inhibitor (PPI), such as the sustained-release capsule of dexlansoprazole, prevents the secretion of gastric acid by specifically blocking (H + / K +) ATPase in gastric parietal cells. Dexlansoprazole stops the final stage of acid generation by only affecting the proton pump. It is lansoprazole's enantiomer (a racemic mixture of R and the enantiomer). In an oral pill, dexlansoprazole is offered in a dual delayed release (DDR) format. Two different enteric-coated granule types with various pH-dependent dissolving characteristics are mixed together in the capsule. The peak plasma concentration-time profiles for dexlansoprazole's dual delayed-release formulation differ; the first peak occurs 1 to 2 hours after treatment, and the second peak occurs 4 to 5 hours later. Dexlansoprazole's typical Cmax and AUC values after oral delivery rise roughly in proportion to the dose. The liver substantially metabolizes dexlansoprazole, which is then eliminated in the urine.
Dosage and administration instructions for Delanix 30mg Capsule are as follows:
For adults:
Erosive Esophagitis:
Gastroesophageal Reflux Disease (GERD):
For patients with mild hepatic impairment (Child-Pugh A), no dose adjustment is necessary. For patients with moderate hepatic impairment (Child-Pugh B), the dose should not exceed 30mg per day. Delanix 30mg Capsule is not recommended for patients with severe hepatic impairment (Child-Pugh C).
For children:
Safety and efficacy have not been established for children under 12 years of age. For children over 12 years old, the dosing recommendations are the same as for adults.
It is important to follow the prescribed dosage and duration of treatment as directed by your healthcare provider. Please consult your doctor or healthcare professional for personalized dosing instructions based on your specific condition.
It is important to note the following interactions and precautions with Delanix 30mg Capsule:
Delanix 30mg Capsule should not be used in the following cases:
Pregnancy: There have been no specific studies conducted with dexlansoprazole use in pregnant women. However, dexlansoprazole is the R-enantiomer of lansoprazole, and observational studies on lansoprazole use during pregnancy have not shown an association of adverse pregnancy-related outcomes with lansoprazole. Animal studies with oral administration of lansoprazole to rats during organogenesis through lactation at 1.8 times the maximum recommended human dexlansoprazole dose showed reductions in offspring femur weight, femur length, crown-rump length, and growth plate thickness (in males only) on postnatal day 21. These effects were associated with a reduction in body weight gain. Pregnant women should be advised about the potential risk to the fetus. It is important to discuss the risks and benefits of dexlansoprazole use during pregnancy with your doctor.
Lactation: There is no information available on the presence of dexlansoprazole in human milk or its effects on breastfed infants or milk production. However, lansoprazole and its metabolites have been found in rat milk. When considering the use of dexlansoprazole, the developmental and health benefits of breastfeeding should be taken into account, along with the mother's clinical need for therapy and the potential adverse effects on the breastfed child from the therapy or the underlying maternal condition.
It is important to have a discussion with your doctor about these conditions to ensure the safe and appropriate use of Delanix 30mg Capsule.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.